QQQ   299.62 (+0.20%)
AAPL   119.05 (+2.11%)
MSFT   214.07 (-0.54%)
FB   276.97 (-0.30%)
GOOGL   1,754.40 (-1.83%)
AMZN   3,168.04 (-0.85%)
TSLA   567.60 (-3.10%)
NVDA   536.06 (+1.06%)
BABA   263.36 (-4.75%)
CGC   28.80 (-0.69%)
GE   10.18 (-2.12%)
MU   64.09 (-0.22%)
AMD   92.66 (+6.27%)
T   28.75 (-0.96%)
NIO   50.53 (-6.43%)
F   9.08 (-0.11%)
ACB   11.68 (+11.56%)
NFLX   490.70 (-0.13%)
BA   210.71 (-2.67%)
GILD   60.67 (+1.07%)
DIS   148.01 (+0.60%)
QQQ   299.62 (+0.20%)
AAPL   119.05 (+2.11%)
MSFT   214.07 (-0.54%)
FB   276.97 (-0.30%)
GOOGL   1,754.40 (-1.83%)
AMZN   3,168.04 (-0.85%)
TSLA   567.60 (-3.10%)
NVDA   536.06 (+1.06%)
BABA   263.36 (-4.75%)
CGC   28.80 (-0.69%)
GE   10.18 (-2.12%)
MU   64.09 (-0.22%)
AMD   92.66 (+6.27%)
T   28.75 (-0.96%)
NIO   50.53 (-6.43%)
F   9.08 (-0.11%)
ACB   11.68 (+11.56%)
NFLX   490.70 (-0.13%)
BA   210.71 (-2.67%)
GILD   60.67 (+1.07%)
DIS   148.01 (+0.60%)
QQQ   299.62 (+0.20%)
AAPL   119.05 (+2.11%)
MSFT   214.07 (-0.54%)
FB   276.97 (-0.30%)
GOOGL   1,754.40 (-1.83%)
AMZN   3,168.04 (-0.85%)
TSLA   567.60 (-3.10%)
NVDA   536.06 (+1.06%)
BABA   263.36 (-4.75%)
CGC   28.80 (-0.69%)
GE   10.18 (-2.12%)
MU   64.09 (-0.22%)
AMD   92.66 (+6.27%)
T   28.75 (-0.96%)
NIO   50.53 (-6.43%)
F   9.08 (-0.11%)
ACB   11.68 (+11.56%)
NFLX   490.70 (-0.13%)
BA   210.71 (-2.67%)
GILD   60.67 (+1.07%)
DIS   148.01 (+0.60%)
QQQ   299.62 (+0.20%)
AAPL   119.05 (+2.11%)
MSFT   214.07 (-0.54%)
FB   276.97 (-0.30%)
GOOGL   1,754.40 (-1.83%)
AMZN   3,168.04 (-0.85%)
TSLA   567.60 (-3.10%)
NVDA   536.06 (+1.06%)
BABA   263.36 (-4.75%)
CGC   28.80 (-0.69%)
GE   10.18 (-2.12%)
MU   64.09 (-0.22%)
AMD   92.66 (+6.27%)
T   28.75 (-0.96%)
NIO   50.53 (-6.43%)
F   9.08 (-0.11%)
ACB   11.68 (+11.56%)
NFLX   490.70 (-0.13%)
BA   210.71 (-2.67%)
GILD   60.67 (+1.07%)
DIS   148.01 (+0.60%)
Log in
ETR:GXI

Gerresheimer AG (GXI.F) Stock Forecast, Price & News

€95.40
-0.65 (-0.68 %)
(As of 11/27/2020 12:00 AM ET)
Add
Compare
Today's Range
€94.60
Now: €95.40
€96.55
50-Day Range
€85.60
MA: €93.19
€101.60
52-Week Range
€50.65
Now: €95.40
€103.70
Volume110,493 shs
Average Volume140,925 shs
Market Capitalization$3.00 billion
P/E RatioN/A
Dividend Yield1.26%
BetaN/A
Gerresheimer AG, together with its subsidiaries, manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through three divisions; Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices. It also provides containers for the delivery of tablets and powders, liquid dosages, ophthalmic and rhinological applications, parenteral packaging applications, oral prescription medications, and cosmetics. The Primary Packaging Glass division offers glass primary packaging for medicines and cosmetics, such as ampoules, cartridges, vials, syrup and dropper bottles, tablet jars, and wide-neck jars, as well as injection, infusion, and transfusion bottles; flacons and pots for fragrances, deodorants, and skin care and decorative cosmetics; and bottles and jars for spirits and food. The Advanced Technologies division develops drug delivery products and platforms, such as micro pumps, which are used to self-administer medication for diabetes or Parkinson's for pharmaceutical and biotech customers. The company was founded in 1864 and is headquartered in Düsseldorf, Germany.
Gerresheimer AG (GXI.F) logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.88 out of 5 stars


Industry, Sector and Symbol

Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+49-211-618100
Employees9,890

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.38 billion
Cash Flow€3.62 per share
Book Value€27.24 per share

Profitability

Miscellaneous

Market Cap$3.00 billion
Next Earnings Date2/18/2021 (Estimated)
OptionableNot Optionable
€95.40
-0.65 (-0.68 %)
(As of 11/27/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive GXI News and Ratings via Email

Sign-up to receive the latest news and ratings for GXI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Gerresheimer AG (GXI.F) (ETR:GXI) Frequently Asked Questions

How has Gerresheimer AG (GXI.F)'s stock been impacted by Coronavirus (COVID-19)?

Gerresheimer AG (GXI.F)'s stock was trading at €59.55 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, GXI stock has increased by 60.2% and is now trading at €95.40.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Gerresheimer AG (GXI.F)?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Gerresheimer AG (GXI.F) in the last year. There are currently 4 sell ratings, 1 hold rating and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Gerresheimer AG (GXI.F)
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Gerresheimer AG (GXI.F)?

Wall Street analysts have given Gerresheimer AG (GXI.F) a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Gerresheimer AG (GXI.F) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Gerresheimer AG (GXI.F)'s next earnings date?

Gerresheimer AG (GXI.F) is scheduled to release its next quarterly earnings announcement on Thursday, February 18th 2021.
View our earnings forecast for Gerresheimer AG (GXI.F)
.

What price target have analysts set for GXI?

9 brokerages have issued 1-year price targets for Gerresheimer AG (GXI.F)'s shares. Their forecasts range from €50.00 to €115.00. On average, they expect Gerresheimer AG (GXI.F)'s share price to reach €89.44 in the next twelve months. This suggests that the stock has a possible downside of 6.3%.
View analysts' price targets for Gerresheimer AG (GXI.F)
.

Who are some of Gerresheimer AG (GXI.F)'s key competitors?

What other stocks do shareholders of Gerresheimer AG (GXI.F) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Gerresheimer AG (GXI.F) investors own include Agilent Technologies (A), Abbott Laboratories (ABT), ACADIA Pharmaceuticals (ACAD), AxoGen (AXGN), Biohaven Pharmaceutical (BHVN), Blueprint Medicines (BPMC), Cree (CREE), Henkel AG & Co. KGaA (HEN3.F) (HEN3), Sarepta Therapeutics (SRPT) and Alcoa (AA).

Who are Gerresheimer AG (GXI.F)'s key executives?

Gerresheimer AG (GXI.F)'s management team includes the following people:
  • Mr. Dietmar Siemssen, CEO & Member of Management Board (Age 57, Pay $1.72M)
  • Dr. Bernd Metzner, CFO & Member of the Management Board (Age 50, Pay $851k)
  • Dr. Lukas Burkhardt, Member of the Management Board (Age 41, Pay $1.04M)
  • Ms. Katja Schnitzler, Group Sr. Director of EHS, CSR & OPEX and Member of Supervisory Board (Age 39, Pay $106k)
  • Mr. Jens-Philipp Briemle, Head of Investor Relations
  • Mr. Jens Kürten, Group Sr. Director of Communication & Marketing and Press Officer of Corp. Media
  • Mr. Helmut Schweiger, MD & GM of Gerresheimer Horsovsky Tyn Plant

What is Gerresheimer AG (GXI.F)'s stock symbol?

Gerresheimer AG (GXI.F) trades on the ETR under the ticker symbol "GXI."

What is Gerresheimer AG (GXI.F)'s stock price today?

One share of GXI stock can currently be purchased for approximately €95.40.

How big of a company is Gerresheimer AG (GXI.F)?

Gerresheimer AG (GXI.F) has a market capitalization of $3.00 billion and generates $1.38 billion in revenue each year. Gerresheimer AG (GXI.F) employs 9,890 workers across the globe.

What is Gerresheimer AG (GXI.F)'s official website?

The official website for Gerresheimer AG (GXI.F) is www.gerresheimer.com.

How can I contact Gerresheimer AG (GXI.F)?

Gerresheimer AG (GXI.F)'s mailing address is Klaus-Bungert-Strasse 4, DUESSELDORF, 40468, Germany. The company can be reached via phone at +49-211-618100.

This page was last updated on 11/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.